Allogene Therapeutics Inc (ALLO)
3.065
+0.10
(+3.20%)
USD |
NASDAQ |
May 03, 16:00
3.065
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Market Cap: 518.27M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 502.20M |
| May 01, 2024 | 493.75M |
| April 30, 2024 | 466.69M |
| April 29, 2024 | 480.22M |
| April 26, 2024 | 488.68M |
| April 25, 2024 | 482.76M |
| April 24, 2024 | 514.04M |
| April 23, 2024 | 569.84M |
| April 22, 2024 | 574.91M |
| April 19, 2024 | 586.75M |
| April 18, 2024 | 585.06M |
| April 17, 2024 | 593.51M |
| April 16, 2024 | 591.82M |
| April 15, 2024 | 600.28M |
| April 12, 2024 | 642.55M |
| April 11, 2024 | 674.68M |
| April 10, 2024 | 688.20M |
| April 09, 2024 | 694.97M |
| April 08, 2024 | 672.99M |
| April 05, 2024 | 669.60M |
| April 04, 2024 | 684.82M |
| April 03, 2024 | 691.59M |
| April 02, 2024 | 688.20M |
| April 01, 2024 | 740.62M |
| March 28, 2024 | 755.84M |
| Date | Value |
|---|---|
| March 27, 2024 | 754.15M |
| March 26, 2024 | 711.88M |
| March 25, 2024 | 725.40M |
| March 22, 2024 | 720.33M |
| March 21, 2024 | 740.62M |
| March 20, 2024 | 749.08M |
| March 19, 2024 | 742.31M |
| March 18, 2024 | 709.34M |
| March 15, 2024 | 787.97M |
| March 14, 2024 | 760.07M |
| March 13, 2024 | 825.17M |
| March 12, 2024 | 828.55M |
| March 11, 2024 | 856.70M |
| March 08, 2024 | 887.06M |
| March 07, 2024 | 939.34M |
| March 06, 2024 | 949.46M |
| March 05, 2024 | 910.67M |
| March 04, 2024 | 920.79M |
| March 01, 2024 | 833.09M |
| February 29, 2024 | 828.03M |
| February 28, 2024 | 863.45M |
| February 27, 2024 | 866.82M |
| February 26, 2024 | 780.81M |
| February 23, 2024 | 765.64M |
| February 22, 2024 | 735.28M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
383.67M
Minimum
Nov 29 2023
6.773B
Maximum
May 22 2020
2.557B
Average
2.491B
Median
Mar 24 2020
Market Cap Benchmarks
| Agenus Inc | 273.35M |
| ANI Pharmaceuticals Inc | 1.417B |
| Vaxart Inc | 125.18M |
| aTyr Pharma Inc | 108.40M |
| PAVmed Inc | 19.26M |
Market Cap Related Metrics
| PS Ratio | 5061.07 |
| Price to Book Value | 1.012 |
| Price | 3.065 |
| Earnings Yield | -69.17% |